Schrodinger Files Q1 2025 10-Q

Ticker: SDGR · Form: 10-Q · Filed: May 7, 2025 · CIK: 1490978

Schrodinger, INC. 10-Q Filing Summary
FieldDetail
CompanySchrodinger, INC. (SDGR)
Form Type10-Q
Filed DateMay 7, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, software, drug-discovery

TL;DR

Schrodinger's Q1 2025 10-Q is in. Check financials for software & drug discovery segments.

AI Summary

Schrodinger, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and business segment information are presented, reflecting the company's ongoing activities in software products and drug discovery.

Why It Matters

This filing provides investors with the latest financial health and operational performance of Schrodinger, Inc. for the first quarter of 2025, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing contains standard financial disclosures for a public company, but the nature of drug discovery and software development inherently carries business and market risks.

Key Numbers

Key Players & Entities

FAQ

What were Schrodinger's reported business segments for the first quarter of 2025?

Schrodinger reported 'SoftwareProductsAndServicesMember' and 'DrugDiscoveryMember' for the period from January 1, 2025, to March 31, 2025.

What is the filing date of this 10-Q report?

This 10-Q report was filed on May 7, 2025.

What is the fiscal year end for Schrodinger, Inc.?

Schrodinger, Inc.'s fiscal year ends on December 31.

What is the SEC file number for Schrodinger, Inc.?

The SEC file number for Schrodinger, Inc. is 001-39206.

What is the SIC code for Schrodinger, Inc.?

The Standard Industrial Classification (SIC) code for Schrodinger, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Schrodinger, Inc. (SDGR).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing